Form 4: Bio-Key International Director Acquires Shares as Compensation

Director Cameron E. Williams acquired 3,897 shares of Bio-Key International stock as compensation for board meeting attendance fees.

Summary

• Cameron E. Williams, a director of Bio-Key International, acquired 3,897 shares of common stock on May 8, 2025.
• The shares were issued under the company's 2023 Stock Incentive Plan as payment for board meeting attendance fees.
• Following the transaction, Williams directly owns 15,684 shares of Bio-Key International.

Sentiment

Score: 6

Explanation: The sentiment is neutral as it reports a standard transaction. It's neither particularly positive nor negative for the company's outlook.

Positives

• The acquisition of shares by a director demonstrates alignment with shareholder interests.

Industry Context

This is a routine disclosure of insider transactions, common for directors receiving stock-based compensation.

Comparison to Industry Standards

• Stock-based compensation for board members is a common practice across publicly traded companies.
• The amount of stock granted is relatively small, suggesting it's a standard form of compensation rather than a significant equity grant.

Stakeholder Impact

• The transaction has a minimal impact on stakeholders as it's a small stock grant to a director.

Key Dates

Keywords

Form 4, Beneficial Ownership, BIO-KEY INTERNATIONAL, BKYI, Director Compensation, Stock Incentive Plan, Cameron E. Williams, Insider Trading